"Triple
negative breast cancer (TNBC) is a minor subtype and has distinctive
aspect of clinical behavior. TNBC often shows rapid and expanding growth
pattern, unlike luminal type. Chemotherapy is the only method as systemic
therapy and shows remarkable effect with relatively high probability; to
the contrary, some of TNBCs show overt progression in a short period
during chemotherapy and develop early recurrence with short survival.
Various molecular targeting therapies are developing, but do not reach our
daily practice. So we tried to explore effective ways of treatment for
TNBC from both previous reports and our experiences in the literature. We
need to consider effective treatment strategy for TNBC, including local
therapy as well as systemic therapy with special care" (Comment
on: Yagata
H et al.: "Current strategy for triple-negative breast
cancer: appropriate combination of surgery, radiation, and
chemotherapy", Breast
Cancer. 2011 Feb 3. [Epub ahead of print])
"What
do you think about NICE clinical guideline for colonoscopic
surveillance to prevent colorectal cancer in people with
ulcerative colitis, Crohn's disease or adenomas?" - Share
your opinion on LinkedIn®
Fragments of History
In the 19th century, the German
scientist Rudolf Virchow (1821-1902), often called the
"founder of cellular pathology", provided the
scientific basis for the modern cytological research and
pathologic study of cancer
Senology.org
opened an on line community (Senology.org - International
Senologic and Oncologic Scientific Community) within the Doctorsbook.com
platform, which will allow you to remain in touch and communicate
with colleagues. Join us
and receive the weekly oncological Doctorsbook Newsletter!